Shard Capital

🎄 Season’s Greetings from Shard Capital 🎄   Wishing you a joyful holiday season filled with warmth, love, and celebration. May the new year bring prosperity, happiness, and exciting opportunities for all.   From everyone at Shard Capital, thank you for being part of our journey.   Happy Holidays and a Happy New Year! #HappyHolidays #SeasonGreetings #ShardCapital

Our latest “Over the Pond” article is out, where Julian Wheeler, Partner and US Equity Specialist, unveils his “2025 (American) Football Team Line-Up” —featuring eleven US stocks. 🏈   Last June, Julian crafted a unique portfolio of US stocks inspired by the ‘Euros’, arranging them in attacking and defending positions. Fast forward to today, and his team is “winning,” with the portfolio currently outperforming the market.   This time, Julian is back with a fresh line-up—eleven US stocks positioned as the ‘Offense’ for his 2025 American Football strategy.   Read the full article below to read Julian’s 2025 #USEquity #StockPicks 👇🏼

Shard Capital is delighted to have acted as Joint Broker to United Oil & Gas and Gas, the oil and gas company with a high impact exploration asset in Jamaica and development asset in the UK, on their oversubscribed Placing raising £0.7 million.   Read the full RNS below 👇🏼   #AIM #CorporateBroking

In our latest podcast, host Neil Williams chats with Ernst Knacke, Julian Wheeler, and Stewart Abrahart about the highs and lows of the 2024 market, their hits and misses in predictions, and their outlook for 2025. In this discussion, the team talk about: 📉 Oil Prices and Global Economic Impact 🏛 Central Banks and Interest Rate Speculations 🌐 Global Market Opportunities and Contrarian Bets 🔭 China's Economic Outlook and European Market Challenges 📈 Latin America's Potential Amid US Trade Policies 🏜 Investment Opportunities in Mexico 📊 India's Market Valuation and Investment Strategies 🟡 Gold and Bitcoin: Market Trends and Predictions 📅 Future Trends Listen in on the conversation below 👇🏼 #2025Outlook #investmentmanagement

Shard Capital is pleased to announce that our Corporate Broking team, acting as sole broker to @ValirRx, has successfully raised £1,183,000 through a conditional placing. Additionally, £140,000 was raised from directors and their closely associated persons, with plans to secure up to £250,000 through a Broker Offer for existing shareholders of our Corporate Client, VALIRX PLC.   Mark Eccleston, CEO of VALIRX PLC commented "I want to thank new and existing shareholders for their support and highlight we will be using the money to further support the preclinical development of CytoLytix. We will continue to build on the first sales from Inaphaea's Biobank, announced on 18 November 2024, which comprises approximately 5,000 vials of Patient Derived Cells from 478 individual cases and 66 types of cancer. Whilst the financial details of the transaction were not released, we are encouraged by the progress made and we believe the biobank holds significant potential for supporting research and generating future revenue streams."   If you are an existing shareholder of ValiRx and would like to participate in the Corporate Offer, please contact us via [email protected]. Read the full RNS below 👇🏼   https://lnkd.in/dcGuRHJv   #LifeScience #CorporateBroking #AIM

“The Permanent Portfolio isn't designed to make you rich; it's designed to keep you from being poor.” ~ Harry Browne, American Libertarian and Finance Author.   In our latest Monthly Review, we reflect on the “Year of the Election”, as voters across the world cast their ballots, introducing new governments, prime ministers, and presidents. Despite new ideas and new promises, many things won’t change; and with this in mind, we introduce our Permanent Portfolio strategy. It emphasises the importance of maintaining a well-prepared, flexible, and diversified portfolio. Such an approach is more critical than ever as we navigate the risks we face in 2025 while also seizing the opportunities that lie ahead.   As usual, we include our brief on #assetclass and #assetallocation comments.    Read the full article below 👇🏼

Shard Capital is delighted to have led the £850,000 fundraise for Emmerson Plc via an oversubscribed placing and subscription of 130,769,229 new ordinary shares. Emmerson PLC is a Moroccan focused potash development company, and the net proceeds of the fundraising will primarily support the Company as it looks at its various options. Read the full RNS below 👇🏼 #AIM #Oversubscription #CorporateBroking

Shard Capital is delighted to have acted as sole placing agent to BSF Enterprise on their oversubscribed placing, raising £500,000.   BSF Enterprise is a world-leading tissue engineering portfolio solving some of the planet’s biggest problems. The funds raised will be strategically allocated across BSF's portfolio of subsidiaries to drive progress in its core projects, such as Lab-Grown Leather Ltd, 3D Bio Tissues Ltd, Kerato Ltd and BSF Enterprise (Hong Kong).   Che Connon, Managing Director of BSF Enterprise PLC, commented:   "We are pleased to complete this raise under difficult market conditions and with the support of current shareholders, which reflects strong investor confidence in BSF's vision and execution capabilities. This capital will advance our ability to achieve critical milestones, including progressing Lab-Grown Leather's technology road map to support scaling its manufacturing process, advancing Kerato's innovative corneal technology, and launching CytoBoost™ to address new markets. We believe these initiatives position BSF for a transformational 2025, paving the way for sustained growth and value creation."    Read the full RNS below 👇🏼   #Biotechnology #CorporateBroking #Oversubscription

Our Head of Investment Research, Ernst Knacke, writes "Mind the productivity gap" in his latest Knacke’s Money Maps column for Portfolio Adviser. In this article, Ernst illustrates that there is a divergence in labour market productivity in the US, UK and Europe, and suggests it’s time to reconsider equities this side of the Atlantic. Read the full article below 👇   #EquityValuationGap #InvestmentManagement #EquityMarkets

In our latest podcast 🎙 we explore the global decline in #FertilityRates and the #AgingPopulation, delving into their profound implications for #EconomicGrowth, #Inflation, expected returns, and #AssetAllocation. The Global Total Fertility Rate (TFR) has dropped significantly 📉 over the past 70 years—from approximately five children per woman in 1950 to just 2.2 in 2021. Alarmingly, more than half of all countries and territories (110 out of 204) now fall below the population replacement level of 2.1 births per woman (source: healthdata.org). We therefore discuss the implications of the declining TFR on global economies and societies, and highlight the investment opportunities we foresee would be worth looking into. Listen in on the conversation below 👇🏼